Retatrutide 16mg $295,00 PRODUCT SHORT DESCRIPTION Retatrutide 16mg is a high-concentration, synthetic single-peptide multi-agonist engineered to simultaneously target the GIP, GLP-1, and glucagon receptors
Common adverse effects , particularly during dose escalation, include: Nausea (reported by 2050% of patients, usually mild to moderate) Vomiting, diarrhoea, or constipation Abdominal discomfort or bloating Reduced appetite (therapeutic effect, but may feel unusual initially) Fatigue or headache These effects typically diminish over several weeks as tolerance develops
Don't skip the salt either
The FDA does not recommend using medications beyond their labeled expiration dates, as the manufacturer cannot guarantee full potency or stability after that point
Br J Pharmacol 164(5):14331444 Raviv Z, Cohen S, Reischer-Pelech D (2013) The anti-cancer activities of jasmonates
Identification of PSD-95 as a major synaptic scaffolding protein